Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001549595-24-000133)

Filing Details

Accession Number:: 0001549595-24-000133
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-10-15 09:16:24
Reporting Period:: 2024-10-14

Accepted Time:: 2024-10-15 09:16:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1549595	Nurix Therapeutics Inc.	NRIX	Pharmaceutical Preparations (2834)	270838048

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1817199	Christine Ring	C/O Nurix Therapeutics, Inc. 1700 Owens Street, Suite 205 San Francisco CA 94158	Chief Legal Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-10-14	3,290	$9.57	27,882	No	4	M	Direct
Common Stock	Disposition	2024-10-14	3,290	$25.00	24,592	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2024-10-14	3,290	$0.00	3,290	$9.57

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
99,679		2030-05-27	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
The stock option vested as to 1/48 of the total shares monthly beginning June 28, 2020, until the option was fully vested on May 28, 2024.